Skip to content

Supplier News

Physicians Formula to go private in buyout

Physicians Formula Holdings Inc. has agreed to be acquired by Swander Pace Capital for $65 million. The cosmetics and skin care company said Wednesday that under the deal, affiliates of Swander Pace will buy all outstanding shares of Physicians Formula common stock for $4.

Sun Pharma to take Taro private

Sun Pharmaceutical Industries Ltd. and Taro Pharmaceutical Industries Ltd. have entered into a merger agreement in which Sun Pharma will buy out Taro for $571 million.

Bristol-Myers wraps up Amylin acquisition

Bristol-Myers Squibb Co. has completed its acquisition of Amylin Pharmaceuticals Inc. Under the deal announced early last month, Bristol-Myers agreed to buy Amylin for $31 per share in cash, pursuant to a cash tender offer and second-step merger, for an aggregate purchase price of about $5.

Perrigo launches opioid pain medication

Perrigo Co. has received final approval from the Food and Drug Administration for its abbreviated new drug application (ANDA) for morphine sulfate 100ml/5% oral solution. The company said Wednesday that it will start shipping the product, a narcotic pain medication, immediately.

Wet Ones lends a hand to teachers

Energizer Personal Care’s Wet Ones brand is supporting TeacherLists.com, a new free service that aims to help America’s classrooms stay fully stocked with supplies.

Nestle USA to get new chairman, CEO

Paul Grimwood, chief executive officer of Nestle UK & Ireland, has been appointed as chairman and CEO of Nestle USA. The world’s largest food company said Friday that Grimwood will move into the new role with the retirement of current Nestle USA chairman and CEO Brad Alford in October.

CoverGirl signs up P!nk

Rock singer P!nk has become the latest in a long line of CoverGirls. The Procter & Gamble makeup brand said Monday that P!nk recently wrapped up her first print advertising campaign with CoverGirl, which will debut in fall. And later this fall, the rock star will be the face of a

Sandoz rolls out generic of Dovonex Cream

Sandoz has introduced in the United States its first-to-file calcipotriene cream (.005%), a topical medication for psoriasis. The company said Friday that its product marks the first generic version of LEO Pharma Inc.’s Dovonex Cream (.005%) in the United States.